GlassScriptPhysician profile
Tiffany L Dellinger
NPI 1164077715
$8,980.76
in general payments reported to CMS, 2019-2025
46 companies · $1,967 in 2025
The $1,967 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,830 · 2022: $1,507 · 2023: $1,785 · 2024: $1,892 · 2025: $1,967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,610 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,610.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,297.36 | 2021-2025 | |
| Novo Nordisk INC | $1,060.94 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $867.77 | 2021-2025 | |
| Amgen INC. | $690.94 | 2021-2025 | Repatha, Evenity, Otezla |
| Lilly USA, LLC | $647.96 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Sumitomo Pharma America, INC. | $447.46 | 2023-2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.35 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $310.24 | 2021-2025 | Spravato, Xarelto |
| Exact Sciences Corporation | $295.93 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $252.89 | 2021-2025 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $242.31 | 2021-2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $232.01 | 2021-2025 | Farxiga, Breztri |
| Astellas Pharma US INC | $197.58 | 2021-2025 | Veozah |
| Esperion Therapeutics, INC. | $178.27 | 2021-2025 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $175.27 | 2021-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $168.76 | 2022-2025 | |
| Biohaven Pharmaceuticals, INC. | $140.25 | 2021 | |
| Glaxosmithkline, LLC. | $124.50 | 2021-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Shield Therapeutics INC | $108.42 | 2025 | |
| Phathom Pharmaceuticals, INC. | $87.25 | 2024 | Voquezna |
| Vivus LLC | $87.22 | 2021 | |
| Dynavax Technologies Corporation | $81.74 | 2024 | Heplisav-B |
| Ardelyx, INC. | $80.68 | 2024 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $77.04 | 2022 | |
| Boston Scientific Corporation | $75.19 | 2024-2025 | Wavewriter Alpha Prime 16, Ams 700 |
| Daiichi Sankyo INC. | $74.42 | 2021-2025 | Injectafer |
| Idorsia Pharmaceuticals US INC | $72.19 | 2023-2024 | Quviviq |
| Edwards Lifesciences Corporation | $58.96 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Eisai INC. | $58.58 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $58.54 | 2021-2025 | Gardasil 9, Capvaxive |
| Cequr Corporation | $50.00 | 2025 | Cequr Simplicity |
| Amarin Pharma, INC. | $44.94 | 2021 | |
| Becton, Dickinson and Company | $34.00 | 2025 | Introducer Needle |
| Gilead Sciences, INC. | $30.53 | 2021 | |
| Abbott Laboratories | $29.55 | 2025 | Freestyle Libre 3 |
| Almatica Pharma LLC | $27.85 | 2021-2022 | |
| Scynexis, INC. | $27.57 | 2022 | |
| Axsome Therapeutics, INC. | $25.77 | 2024 | Auvelity |
| Ascensia Diabetes Care US INC. | $24.56 | 2025 | |
| Lundbeck LLC | $19.92 | 2023 | Vyepti |
| Dexcom, INC. | $16.90 | 2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $15.35 | 2022 | |
| Harmony Biosciences LLC | $15.15 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.80 | 2024 | Caplyta |
| Endo Pharmaceuticals INC. | $12.00 | 2021 | |
| Genentech USA, INC. | $3.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Dellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.